Tarodent

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tarodent

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate
Form Oromucosal Solution (Medicated Mouthwash)
Pharmacological Class Antiseptic and Antimicrobial Agent
Origin Synthetic (Biguanide Derivative)
Route Topical/Oromucosal
Manufacturer Taro Pharmaceutical Industries

What Type of Medicine is Tarodent?

Tarodent is defined as a specific brand of medicated mouthwash administered as an oromucosal solution intended for targeted, topical use within the oral cavity. Its official pharmacological classification is as an Antiseptic and Antimicrobial Agent. This classification establishes Tarodent as a therapeutic agent designed to actively modify the microbial population, a capacity utilized in oral care. The high-level purpose of this stomatological preparation, manufactured by Taro Pharmaceutical Industries, is linked to its ability to achieve a sustained reduction in the concentration of microorganisms, which is a key factor in supporting overall oral health.

Composition and Origin: The Role of Chlorhexidine Gluconate

The effectiveness of Tarodent is derived from its single active ingredient, Chlorhexidine Gluconate. This key compound is a synthetic substance belonging to the chemical class of biguanide derivatives. Tarodent is manufactured as an aqueous solution, ensuring efficient distribution of the active substance across oral surfaces. Chlorhexidine Gluconate is a cationic bis-guanide, a chemical property that enables it to strongly bind to the negatively charged surfaces within the mouth, a characteristic that is critical for sustained antimicrobial effect and distinguishes its action from non-substantive rinses.

General Purpose in Oral Health

The general purpose of this antiseptic is to exert a localized, sustained germicidal effect against a broad spectrum of microorganisms. This action works through the physical disruption of microbial cell membranes, leading to the rapid elimination of bacteria and certain yeasts. The resulting reduction in the microbial burden is intended to support the robust maintenance of oral hygiene and aid in controlling the development of dental plaque, often utilized in scenarios requiring strong microbiological control.

What side effects are possible with Tarodent?

Possible Side Effects and Safety Information

The safety profile for this oromucosal solution is based on classifications from official regulatory documents and centers primarily on effects within the oral cavity. Adverse reactions are grouped by incidence and the body system affected.

Adverse Reaction Scope

Category Description
Key adverse reaction categories Local effects in the mouth (staining, taste changes, irritation), localized swelling, and systemic allergic reactions.
Frequency classification Common (e.g., taste disturbance, staining); Uncommon (e.g., superficial tongue discoloration); Very Rare (e.g., anaphylactic shock).
System-organ classes involved Gastrointestinal disorders (oral irritation, staining); Nervous system disorders (taste disturbances); Immune system disorders (hypersensitivity).
Serious adverse reactions Anaphylactic shock and severe Hypersensitivity Reactions (involving acute respiratory symptoms or collapse) are documented as very rare occurrences.
Population-specific safety The FDA label classifies the oral rinse formulation as Pregnancy Category B; safety and effectiveness are not established in children under 18 (U.S. context).
Exposure-related patterns Transient taste disturbance and burning sensation are more likely on initial use and typically diminish with continued exposure. Staining and discoloration are not permanent and usually resolve after treatment cessation.
Safety restrictions Contraindicated in individuals with known hypersensitivity to Chlorhexidine Gluconate or its components. Incompatibility is noted with anionic agents found in regular toothpastes.

Connection to the Overall Safety Profile

The official safety information frames the medicine’s risk profile around frequently encountered, transient oral and taste effects, which are reversible, alongside a required disclosure of the extremely rare potential for severe allergic events as documented in regulatory warnings. This structure categorizes effects by incidence and physiological domain, consistent with regulatory expectations.

Overdose and Emergency Response

The official documentation addresses overdose for Tarodent, an oromucosal solution, exclusively in the context of accidental oral ingestion. The medication is not intended to be swallowed.

Documented overdose presentations may include localized gastric distress, nausea, and stomach pain. Due to the presence of ethanol in some formulations, swallowing large volumes may lead to systemic effects, including signs consistent with alcohol intoxication, such as slurred speech or a staggering walk.

Immediate medical attention must be sought in specific scenarios. Regulators specify that medical care is required if a small child (approximately 10 kg body weight) ingests more than 4 ounces (approximately 120 mL) of the rinse, or if any person develops signs of alcohol intoxication. In all cases of suspected ingestion of large volumes, individuals should immediately contact a Poison Control Center.

There is no specific antidote documented for Chlorhexidine Gluconate ingestion; management is limited to symptomatic and supportive treatment. Furthermore, a separate, life-threatening emergency is a severe allergic reaction (anaphylaxis), which can involve wheezing, swelling of the face, or shock. If these symptoms occur, the product must be stopped immediately and emergency services (e.g., 911) called without delay.

Therapeutic Uses of Tarodent

Main Uses and Therapeutic Intent

Tarodent is a specialized oral care solution formulated primarily for the management and prevention of gum-related inflammatory conditions. Its clinical application focuses on maintaining the integrity of periodontal tissues and reducing the presence of pathogenic microorganisms within the oral cavity.

Primary Indications

  • Gingivitis Management: It is used to treat the early stages of gum disease, characterized by inflammation, redness, and swelling of the gingival margins.
  • Plaque Control: The formulation acts as an anti-plaque agent, helping to inhibit the formation and accumulation of bacterial biofilms on tooth surfaces and along the gum line.
  • Post-Surgical Care: It is frequently employed following dental procedures or oral surgeries to maintain a sterile environment and support the natural recovery of oral tissues.
  • Oral Hygiene Maintenance: In cases where mechanical brushing is difficult or insufficient, it serves as a chemical adjunct to ensure comprehensive oral cleanliness.

Benefits and Mechanism of Action

Tarodent provides several therapeutic benefits aimed at improving overall oral health through its antimicrobial and anti-inflammatory properties.

Reduction of Inflammation

By targeting the bacteria responsible for irritation, Tarodent helps to resolve bleeding gums and reduce the sensitivity associated with inflamed tissue. This stabilization of the gingival environment is essential for preventing the progression of gingivitis into more severe forms of periodontal disease.

Antimicrobial Protection

The active components in Tarodent provide a broad-spectrum antimicrobial effect. This helps to reduce the total bacterial load in the mouth, specifically targeting the anaerobic species often linked to dental decay and persistent halitosis (bad breath).

Support for Tissue Recovery

By keeping the affected areas clean and free from excessive bacterial colonization, Tarodent creates an environment conducive to the healing of minor oral lesions, ulcers, and irritated mucous membranes. This protective barrier is particularly beneficial for patients with sensitive oral environments or those undergoing orthodontic treatment.

Eligibility and Restrictions for Use

Tarodent eligibility is defined by official regulatory labeling regarding patient age, hypersensitivity status, and specific clinical conditions.

Who Must Not Use Tarodent (Contraindications)

The medicine is contraindicated (must not be used) in any individual with a known hypersensitivity or allergy to the active ingredient, Chlorhexidine Gluconate, or to any of the inactive ingredients found in the oral rinse formulation [FDA Label / HPRA SmPC].

Age-Group and Condition-Based Restrictions

Population Group Regulatory Eligibility Status (Official Labeling)
Children under 18 Use Not Established: Clinical safety and effectiveness have not been established by regulatory authorities; use is therefore not recommended [DailyMed].
Adults (18+) Approved Use: The primary population for whom the medicine is indicated as part of a treatment program for gingivitis [FDA Label].
Pregnant Women Conditional Use: Classified as U.S. Pregnancy Category B; use is permitted only if clearly needed [FDA Label].
Nursing Mothers Caution Required: It is unknown if the drug is excreted in human milk; caution should be exercised during administration [FDA Label].
Dental Restorations Exclusion Advised: Patients with rough or open-margined anterior dental restorations should be excluded from treatment if permanent staining is unacceptable [FDA Label].

Eligibility criteria confirm the product is designed for adult use in managing gingivitis symptoms and is strictly prohibited in cases of known allergy.

What should I know about interactions with other medicines?

Tarodent Interactions with other medicines and products

The interaction profile of Tarodent (Chlorhexidine Gluconate Oromucosal Solution) is primarily defined by its topical route of administration and minimal systemic absorption, according to official government regulatory documentation.

Documented Systemic Interaction Profile

No systemic drug-drug interactions, metabolic interactions (e.g., CYP enzyme effects), or transporter-mediated interactions (e.g., P-gp) are officially documented in prescribing information. The negligible systemic exposure means that co-administration with other medicines is not typically associated with changes in plasma levels (AUC or Cmax).

Local and Procedural Constraints

The most relevant documented interaction type is a local physical interference that affects the drug's effectiveness:

  • Interacting Substances: Other oral rinses or mouthwashes, water, food, and beverages.
  • Official Restriction: Regulatory labels mandate a timing separation to maintain the local antimicrobial action, or substantivity, of the active ingredient. Patients are instructed to avoid rinsing the mouth (with water or other mouthwashes), brushing teeth, eating, or drinking for a period of at least 30 minutes after using the rinse.

Contraindications and Population Notes

The only absolute prohibition for use is a known hypersensitivity to Chlorhexidine Gluconate or any other component of the solution. Regarding specific populations, regulatory documents note that data on interaction relevance in the Geriatric Population (subjects aged 65 and over) is limited, advising general caution.

Mechanism of Action

Selective Modulation of Key Receptors

Tarodent primarily works by acting as an allosteric modulator at a defined family of cell surface receptors. This mechanism selectively fine-tunes the receptor's sensitivity to its natural mediators, rather than functioning as a direct agonist or antagonist. This initial step initiates the mechanistic cascade by adjusting the fundamental activity level of the core signaling system at the molecular level.

Modulation of Signal Transduction Cascades

The interaction at the receptor modulates the associated intracellular signal transduction pathway. Tarodent influences key molecular steps downstream of the receptor, resulting in the modulation of the excessive propagation of signals through the cellular mechanism. This targeted pathway interference is relevant in states where specific endogenous mediators dominate the physiological activity.

Effect on Physiological Regulation

By selectively limiting signaling activity, Tarodent facilitates the activity of intrinsic regulatory feedback mechanisms within the targeted pathways. This action modifies overactive or dysregulated physiological responses within the affected systems, influencing the equilibrium of signaling systems and resulting in specific physiological adjustments that characterize the drug's mechanistic influence on the body.

Dosage and Administration Information

Tarodent is an antiseptic solution used strictly through the topical, oromucosal route of administration. This method means the product is applied directly inside the mouth as an oral rinse, and it is not intended for ingestion. The standard approach for use involves a fixed volume of the 0.12% solution. For each application, 15 mL of the undiluted solution must be measured and utilized.

The regimen is structured around a twice-daily frequency, typically in the morning and evening, to achieve the sustained presence of the active ingredient on oral surfaces. Procedurally, the solution must be used after routine oral hygiene, such as brushing and flossing. Once measured, the 15 mL dose is to be rinsed or swished continuously in the mouth for a full 30 seconds. Following this period, the solution must be fully expelled and never swallowed.

A critical step in the administration protocol involves mandatory post-use restrictions: to avoid washing away the active substance, individuals must refrain from immediately rinsing with water, eating, or drinking for a specified period, typically 30 minutes after use. Regarding specific populations, the use of 0.12% oral rinse is not recommended in patients under 18 years of age. These instructions define the approach to utilizing the medicine.

Recent Clinical Evidence

Tarodent: Clinical Evidence Overview

Evidence for Use in Gingivitis and Plaque Accumulation

Research for this indication examined its use alongside standard dental hygiene procedures. Studies primarily rely on controlled clinical trials, including Randomized Controlled Trials (RCTs). Research examined populations of adults presenting with mild to moderate gingival inflammation. The trials assessed short-term to mid-term changes, typically following participants for up to six months.

Studies observed patterns related to plaque accumulation. Data show patterns related to Plaque Index scores when the rinse was used alongside regular brushing and flossing. Research highlights the measured differences in gingival health markers, including those used to track bleeding gums, during the study period.

The evidence addresses conditions characterized by fluctuating manifestations of inflammation, but certainty remains low regarding outcomes in individuals with moderate to severe inflammation, as data for these specific groups remain insufficient. Furthermore, long-term effects are not fully established beyond the typical six-month follow-up durations.

Evidence for Post-Procedure Support and Microbial Control

Research examined the rinse as a part of post-operative support following specific dental procedures. The research explored short-term symptom changes following specific dental interventions, such as tooth extractions or periodontal surgery. Studies monitored outcomes linked to inflammatory or irritative states and localized microbial load during the immediate healing period.

Studies reported patterns observed where localized bacterial counts were monitored during the immediate post-operative period. Studies report how symptoms evolved in the observed populations. However, comparative evidence is lacking for certain aspects of post-operative healing, and follow-up durations were limited.

Evidence for Other Oral Conditions (e.g., Candidiasis)

Clinical trials evaluated the rinse in conditions associated with acute or disruptive episodes, such as oral candidiasis and denture stomatitis. Research examined microbiological outcomes, specifically monitoring fungal colony counts, alongside patient-reported outcomes describing perceived discomfort. The research base for these conditions often relies on modest sample sizes.

What is Still Uncertain About the Research

Certainty remains low regarding many long-term aspects of its use. Follow-up durations were limited across the majority of major studies, meaning long-term effects are not fully established. Evidence quality varies across studies, especially for post-procedure and other oral conditions where sample sizes were modest. Findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Tarodent (FAQ)


Q: Why do some people say Tarodent helped their gum issues?

Official documents state that Tarodent is indicated for the treatment of gingivitis, which is inflammation of the gums. The medicine works by reducing the amount of microbes, such as bacteria, in the mouth. This reduction in the microbial population is described as the mechanism intended to address the symptoms of gingivitis, such as bleeding and swelling.


Q: Is Tarodent available over the counter, or only by prescription?

Official regulatory designations typically classify Tarodent as a prescription-only medicine (Rx Only). It is dispensed under the direction of a healthcare professional.


Q: Is Tarodent the same type of medicine as [similar drug name]?

Official bodies classify Tarodent as an Antiseptic and Antimicrobial Agent (specifically, a biguanide derivative). This establishes its pharmacological class, but official information does not compare it to or comment on other specific drug names.


Q: Is there a generic version of Tarodent available?

Official regulatory databases confirm that the active ingredient, Chlorhexidine Gluconate oral rinse 0.12%, is manufactured and approved by various companies. This suggests the availability of other products containing the same active substance.


Q: What is the difference between Tarodent and other common mouth rinses?

Tarodent is a medicated oral rinse classified as a therapeutic antiseptic, meaning it has a defined pharmaceutical effect. A key characteristic is the ability of its active ingredient to bind strongly to surfaces inside the mouth, providing a sustained antimicrobial effect that differs from non-medicated rinses.


Q: Can Tarodent be used for mouth sores or ulcers?

The official indication for Tarodent is strictly limited to the treatment of gingivitis. Regulatory documents do not list use for general mouth sores or ulcers. The official documents focus exclusively on its approved purpose.


Q: Are headaches a common side effect of using Tarodent?

Headaches are not listed among the most common adverse effects in official safety documents. Common side effects reported are generally localized to the oral cavity, such as taste alteration and staining.


Q: Is a change in taste noticed by many people when using Tarodent?

Yes, an alteration in taste perception is listed as a common side effect. The effect is often described as transient and may lessen with continued use of the rinse.


Q: Do you get stains on your teeth from using Tarodent?

Yes, an increase in staining of the teeth, tongue, and certain dental restorations is a common adverse effect. The color is usually brown. Regulatory information states that professional dental cleaning can typically remove most of the staining.


Q: Can Tarodent cause an allergic reaction?

Official warnings document the potential for a severe whole-body allergic reaction, known as a hypersensitivity reaction, which can include very rare instances of anaphylactic shock. For this reason, the medicine is contraindicated (must not be used) in individuals with a known allergy to its components.


Q: Is Tarodent safe to use if I have high blood pressure?

Due to its topical route of administration, the medicine has minimal systemic exposure. Official regulatory documents state that no systemic drug-drug interactions are officially documented, and high blood pressure is not listed as a contraindication or special warning for use.


Q: Can children or teenagers use Tarodent?

No. The safety and effectiveness of Tarodent oral rinse have not been established in pediatric patients (individuals under 18 years of age) by regulatory authorities. Therefore, use is not recommended in this younger population, as directed by official documents.


Q: Is Tarodent generally considered safe for older adults?

Regulatory documents indicate that clinical data regarding drug interactions and effects specifically in the Geriatric Population (65 years and older) is limited. General caution is noted in this population, consistent with the official product information.


Q: Can Tarodent be used during pregnancy, according to official documents?

The oral rinse formulation is classified as U.S. Pregnancy Category B. This designation means that use is permitted only if clearly needed. Official documentation advises against unnecessary use during pregnancy.


Q: Is it okay to use Tarodent while breastfeeding?

Official product information notes that it is unknown if the drug is excreted in human milk following topical use. Regulatory documents advise that caution should be exercised when considering administration to nursing mothers.


Q: Are there any specific foods or drinks that should be avoided while using Tarodent?

Official instructions mandate avoiding all food and beverages for 30 minutes after use to maintain efficacy. To minimize the risk of dental staining, some regulatory documents advise patients to avoid consuming tannin-containing foods or drinks, such as coffee, tea, and wine, for a period of time after rinsing.


Q: How long after using Tarodent should I wait before eating or drinking?

Official administration instructions state that you must refrain from eating or drinking for a period of at least 30 minutes after using the oral rinse. This time is necessary to ensure the active ingredient maintains its therapeutic effect in the mouth and is not immediately rinsed away.


Q: Why does the official document mention using Tarodent for only a limited time?

Regulatory documents advise for reevaluation at intervals no longer than six months. The duration of use is limited because prolonged, continuous exposure may lead to increased side effects like staining. Furthermore, clinical trial data on long-term effects beyond six months is not fully established.


Q: Is Tarodent a long-term treatment or a short-term one?

The medicine is generally used for a short-term to mid-term period as a therapeutic support alongside professional dental care. Official administration advises that use should be for a specific course, with reevaluation required at least every six months.


Q: Is it normal to feel a burning or tingling sensation when using it?

Yes, a transient burning or tingling sensation is noted as a possible local reaction, especially when the rinse is used for the first time. Official information states that this feeling typically diminishes with continued use of the rinse.


Q: Do you need to dilute Tarodent before using it?

No. The official instructions for use specify that the standard dosage involves using 15 mL of the undiluted solution for rinsing, as dilution is not mentioned in the regulated administration protocol.


Q: What is the expected duration of action for Tarodent after a single use?

Official product information notes that the active ingredient binds strongly to surfaces within the mouth. It is then slowly released into oral fluids to provide a sustained antimicrobial effect. The specific duration of germicidal activity is not quantified in a number of hours on the regulatory label.


Q: Can Tarodent be purchased in other countries besides the US?

The active ingredient in Tarodent, Chlorhexidine Gluconate oral rinse 0.12%, is registered and approved for use by major regulatory bodies in several international regions, including the EU, Canada, Australia, and Japan. However, the specific brand name 'Tarodent' may differ by country.


Q: Are there warnings about driving or operating machinery while using Tarodent?

Due to its topical route of administration and minimal absorption into the bloodstream, official documents typically state that the medicine is not expected to affect the ability to drive or operate machinery.


Q: Has Tarodent been approved by the FDA?

Yes. The product and its various equivalents containing Chlorhexidine Gluconate oral rinse 0.12% have received marketing authorization and approval from the U.S. Food and Drug Administration (FDA).


Q: Does the package insert for Tarodent include information about drug abuse potential?

No. Due to its topical route of administration and minimal systemic exposure, official regulatory documents do not list Tarodent as a controlled substance and do not include sections discussing drug abuse potential or physical dependence.


Q: What are the signs of an overdose with Tarodent?

Ingesting amounts significantly larger than the prescribed dose may lead to gastric distress, which could include nausea. Given the product contains alcohol, overdose in a small child could also result in signs resembling alcohol intoxication.


Q: What are the official warnings about contact lenses and Tarodent?

Official warnings instruct users to keep the mouthwash away from the eyes. If accidental contact occurs, users are advised to rinse the eyes well with clean water immediately.

How should Tarodent be stored and disposed of?

How to Store and Dispose of Tarodent?

Tarodent (Chlorhexidine Gluconate oral rinse) must be stored and disposed of according to the instructions on its official regulatory label to ensure product stability and safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F), with excursions permitted up to 30 C. The medicine must be kept in its original container and the closure must be kept tightly closed.

Disposal and Safety

All medicine must be kept out of the reach of children. Unused or expired Tarodent should be disposed of using local regulations or an official drug take-back program. It is prohibited to dispose of the solution by pouring it into the toilet or down any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tarodent found in:

A-Z Index: